TP53 and gastric cancer: Our studies showed that IRTKS overexpression promoted tumor suppressor p53 ubiquitination and degradation in gastric cancer cells by recruiting the p53-specific E3 ubiquitin ligase MDM2 (Huang et al, 2018).